Macao, China Medical Device Registration Basics

1. Key takeaways

Macao, China has imposed mandatory market access for medical devices with effect from July 1, 2026. Under Law No. 12/2025 establishing the regime of supervision and administration of medical devices, devices are classified by risk into four classes — Class I (low risk), Class IIa (medium-low risk), Class IIb (medium-high risk) and Class III (higher risk). Two corresponding pathways apply: Class I and Class IIa devices require filing, while Class IIb and Class III devices require registration. Except in the situations exempted by law, only medical devices that have completed registration or filing may circulate in Macao, China. Registration is valid for five years, while a filing has no fixed validity period. The official registration fee is only MOP 500.

In practical terms, this means that any device offered in Macao, China must first be assigned to one of the four risk classes, and the class then dictates the access route, the applicant entity, the documentation set and the timeline. Because only registered or filed devices may circulate, purchasers can verify the registration or filing record before contracting, so the record is not a formality but the entry ticket to the market.

2. Legal basis

The obligations, pathways and fees summarised above rest on the following instruments, as published in the Official Gazette of the Macao Special Administrative Region and in materials issued by the Drug Administration Bureau.

3. Expert insights

Insight 1: Registration and filing differ by risk stratification, not by degree of difficulty. The law uses a single provision (Article 9) to establish the mandatory nature of both, which shows that the legislator treats them as two branches of one system rather than two independent regimes. The most common corporate mistake is to describe every case as registration. In Macao, filing is a separate pathway with its own statutory procedure, its own filing notice and its own set of filer obligations; the two terms must not be used interchangeably in submissions or correspondence.

Insight 2: The difference in validity periods shapes the long-term cost of compliance. Registration is valid for five years and must be renewed by applying within 90 to 180 days before expiry; a filing has no validity period. This means that once Class I and Class IIa products complete filing, there is no recurring renewal burden, although the rules on cancellation and change of a filing (Articles 26 and 28) continue to apply and must be monitored throughout the product life cycle.

Insight 3: Official fees are very low; the barrier lies in the applicant entity and the dossier, not in the cost. Registration costs MOP 500, registration renewal MOP 200 and reissue of a certificate of registration MOP 200. By comparison, a manufacturing licence costs MOP 9,000 and a trading licence MOP 2,000 — the licences cost far more than the product registration itself. These figures make the point directly: the difficulty of market access in Macao is who is qualified to apply and whether the dossier is complete, not the regulatory fees.

Insight 4: Circulation is a legal concept that runs through the entire chain. The wording of Article 9(1) is that only registered or filed devices may circulate in Macao, covering manufacturing, import and export, wholesale and retail. Completing product registration does not mean a company may operate. Business activities separately require the corresponding licence (Articles 31 to 38), and the two approvals run on parallel tracks.

4. Practical recommendations

• Classify first, then choose the pathway: the first step of any project is to determine the class, and only then decide between filing and registration; a classification error forces the entire route to be redone.
• Plan the product line and the licence line in parallel: product registration/filing and the manufacturing and trading licences are two independent application tracks and must be scheduled separately.
• Budget for entity plus dossier, not for official fees: total official fees are usually below MOP 10,000; the real cost sits in establishing the local entity, appointing the technical director and preparing the dossier (practical estimate).
• Unify terminology in external documents: use the statutory terms registration and filing consistently in tender documents and customer communications, and avoid expressions such as listing or enrolment that do not exist in the local system.

5. Verification checklist

• □ Risk classification completed and the class confirmed as Class I, IIa, IIb or III
• □ Applicable pathway determined (filing for Class I/IIa, registration for Class IIb/III)
• □ Confirmed whether a statutory exemption applies (Article 9(3))
• □ Product registration/filing and business licence tracks planned in parallel
• □ Budget prepared on the basis of entity and dossier rather than official fees
• □ External terminology unified to registration and filing

Regulatory information verified as of October 29, 2026. The regulations, guidance and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as of that date; where official documents have been updated, the latest published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Macao, China. Our team manages Health Bureau (SSM) pre-market registration and notification procedures, prepares Portuguese/Chinese-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com